Clorox Company CLX

La empresa Clorox es un fabricante y comercializador de productos para consumidores y profesionales. La empresa vende sus productos principalmente a través de tiendas minoristas, supermercados, clubes de almacén, tiendas de dólar, ferreterías, farmacias, tiendas de mascotas y militares, canales de comercio electrónico de terceros y propios, y distribuidores. La empresa opera a través de cuatro segmentos: Salud y Bienestar, Hogar, Estilo de Vida e Internacional. El segmento de Salud y Bienestar consta de productos de limpieza, productos profesionales y productos de vitaminas, minerales y suplementos. Su segmento de Hogar consta de productos para gatos, bolsas y envolturas, y productos para asar a la parrilla. Su segmento de Estilo de Vida consta de alimentos, productos naturales de cuidado personal y sistemas de filtración de agua. Su segmento Internacional consta de productos vendidos fuera de los Estados Unidos. La empresa comercializa varias marcas de consumo, como el blanqueador y los productos de limpieza homónimos, los limpiadores Pine-Sol, el removedor de obstrucciones Liquid-Plumr y los productos para el hogar Poett.

Con 12 acciones de CLX (USD 986,75) habrías recibido USD 59,64 en dividendos en los últimos 12 meses.

• The Motley Fool 3 oct

  Clorox is Dealing With Several Years of Challenging Circumstances

  Clorox has faced significant difficulties since the economic reopening following the pandemic boom. The company, which experienced strong business during COVID-19, has struggled with multiple challenges in recent years as consumer behavior and market conditions have normalized.

  

• Zacks Investment Research 1 oct

  Will Innovation and Digital Expansion Efforts Drive Clorox's Growth?

  The Clorox Company is executing a strategic transformation focused on rebuilding market share and enhancing growth through the GOJO Industries acquisition, which significantly expands its health and hygiene portfolio to over half of net sales. The company has completed its five-year digital transformation program and expects productivity benefits from fiscal 2027 onwards. Clorox is increasing innovation spending in health, wellness, and pet care categories while improving brand relevance through targeted promotions and packaging improvements.

  

• Zacks Investment Research 1 oct

  Is the Options Market Predicting a Spike in Clorox Stock?

  The Clorox Company (CLX) is experiencing elevated implied volatility in its October 2026 put options, signaling market expectations for significant price movement. However, the fundamental outlook remains weak, with Clorox holding a Zacks Rank #3 (Hold) rating and six analysts downgrading estimates over the past 60 days, reducing consensus earnings estimates from $1.26 to $0.99 per share.

  

• Zacks Investment Research 30 sept

  Colgate's Innovation and Premiumization Drive: Can Momentum Persist?

  Colgate-Palmolive is strengthening its market position through innovation, premiumization of oral-care products, and expansion in emerging markets. The company is introducing differentiated products targeting whitening, sensitivity, and gum health, while leveraging its strong global brands. However, sustaining momentum depends on balancing pricing with volume, successful product launches, and cost management. Colgate trades at a premium valuation (21.5X forward P/E vs. industry 18.4X) with modest EPS growth projected at 4.9% for 2026 and 5.2% for 2027.

  

• Zacks Investment Research 21 sept

  Will Pricing Sustain Procter & Gamble as Volume Growth Stays Elusive?

  Procter & Gamble faces a $1.4 billion after-tax earnings headwind in fiscal 2027 as it attempts to balance pricing strategies with volume growth in a challenging consumer environment. While pricing contributed to 1% organic sales growth in fiscal 2026, volume remained flat in Q4. PG plans to shift toward more balanced growth through innovation, promotions, and disciplined pricing rather than relying solely on price increases, which risk consumer trade-downs and reduced purchase frequency.